These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16989040)

  • 21. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switzerland: one year's experience with new regulations and a new agency.
    Voelksen R
    Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Medical Device Safety Act of 2009.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Apr; 360(15):1550-1. PubMed ID: 19297562
    [No Abstract]   [Full Text] [Related]  

  • 24. Walking the drug regulatory tightrope.
    Dove A
    Nat Biotechnol; 2003 May; 21(5):495-8. PubMed ID: 12721571
    [No Abstract]   [Full Text] [Related]  

  • 25. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 26. Express preemption and premarket approval under the Medical Device Amendments.
    Scandaglia GJ; Tully TL
    Food Drug Law J; 2004; 59(2):245-64. PubMed ID: 15318395
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec; 62(242):66179. PubMed ID: 10179302
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical device recalls from 2004 to 2006: a focus on Class I recalls.
    Villarraga ML; Guerin HL; Lam T
    Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400
    [No Abstract]   [Full Text] [Related]  

  • 29. Achieving medical device safety in an era of globalization.
    Meritz JK; White TL
    Food Drug Law J; 2008; 63(3):647-55. PubMed ID: 19031664
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug review "behind the curtain": a response to Professor Struve.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971
    [No Abstract]   [Full Text] [Related]  

  • 32. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA
    Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. King v. Collagen Corporation: FDA approval insulates medical device manufacturers from state common law liability.
    Kronenberg AW
    J Contemp Health Law Policy; 1995; 11(2):563-87. PubMed ID: 10184353
    [No Abstract]   [Full Text] [Related]  

  • 34. US and European postmarket clinical data requirements.
    Donawa M
    Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing supplement safety--the FDA's controversial proposal.
    Cohen PA
    N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
    [No Abstract]   [Full Text] [Related]  

  • 36. Forces reshaping the performance and contribution of the U.S. medical device industry.
    Benson JS
    Food Drug Law J; 1996; 51(2):331-6. PubMed ID: 11822326
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond the US submisson process.
    Donawa M
    Med Device Technol; 2004 Apr; 15(3):30-2. PubMed ID: 15255536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical device reporting: issues with Class III medical devices.
    Zigler J; Walsh J; Zigler J
    Food Drug Law J; 2007; 62(3):573-80. PubMed ID: 17915398
    [No Abstract]   [Full Text] [Related]  

  • 39. Bilski blundering biotech.
    Simmons WJ
    Nat Biotechnol; 2009 Mar; 27(3):245-8. PubMed ID: 19270670
    [No Abstract]   [Full Text] [Related]  

  • 40. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.